As a volunteer for the American Cancer Society Cancer Action Network (ACS CAN), I am writing to you regarding the impact of COVID-19 on the cancer research ecosystem. COVID-19 has meant that vital research and clinical trials across the country are stalled. Funding is needed to ensure that labs and researchers can restart their operations when it is safe to do so. In the next COVID-19 emergency response package, I ask that the Senate include at least $10 billion for the National Institutes of Health (NIH) in order to re-open labs and re-start clinical trials. Without this funding, we are in danger of losing some of the progress we have made in the fight against cancer.